4 ms·
Good luck, but you should consider that this isn’t a ”researcher is good/bad” issue, this is a ”global pharma race for billions in profits” issue with all kinds
by waihtis 6y ago
Good luck, but you should consider that this isn’t a ”researcher is good/bad” issue, this is a ”global pharma race for billions in profits” issue with all kinds of interference from management, finance, etc.
- yread 6y agoMore like "this stuff is super difficult/they have validated it on very small samples so only do it if you're feeling lucky"
- jmeister 6y agowhat’s wrong with profits? As long as they lead to delivering to the public/govt. what is needed?
- waihtis 6y agoThe argument is not against profits but rather there is a huge first-to-market benefit here, which might have an impact on usual quality and safety measures.